United Kingdom — National Institute for Health and Care Research
Tracked across 6 events · 43 articles · First seen Aug 14, 2025 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The United Kingdom — National Institute for Health and Care Research, the NHS's drugs watchdog, has approved the use of semaglutide (Wegovy) for overweight and obese patients with specific heart and circulatory problems.
Mar 31, 2026 · 7 articles
Tech
Impact: United Kingdom — National Institute for Health and Care Research approved the use of pembrolizumab on the NHS following a commercial agreement, facilitating its availability to eligible patients.
Jun 25, 2026 · 6 articles
Tech
Impact: The United Kingdom — National Institute for Health and Care Research funded the study, enabling the research into weather's impact on mental health service demand.
Jun 29, 2026 · 7 articles
Tech
Impact: The United Kingdom — National Institute for Health and Care Research provides prescribing guidelines for semaglutide, which may be influenced by the study's findings on weight regain.
Mar 04, 2026 · 6 articles
Business
Impact: United Kingdom — National Institute for Health and Care Research has endorsed Tirzepatide for eligible patients in England, with a staged introduction due to cost-effectiveness concerns.
Aug 14, 2025 · 10 articles
United Kingdom — National Health Service
↔
United Kingdom — National Institute for Health and Care Research
United Kingdom — National Health Service
↔
United Kingdom — National Institute for Health and Care Research
United States — National Institutes of Health
↔
United Kingdom — National Institute for Health and Care Research
United States — National Institutes of Health
↔
United Kingdom — National Institute for Health and Care Research
ERGEN INTELLIGENCE
Track United Kingdom — National Institute for Health and Care Research live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard